Allstate Corp Raises Position in UnitedHealth Group Incorporated (NYSE:UNH)

Allstate Corp raised its stake in shares of UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 3,187.1% in the 4th quarter, according to its most recent disclosure with the SEC. The firm owned 27,480 shares of the healthcare conglomerate's stock after purchasing an additional 26,644 shares during the period. UnitedHealth Group accounts for about 0.4% of Allstate Corp's investment portfolio, making the stock its 28th biggest holding. Allstate Corp's holdings in UnitedHealth Group were worth $13,901,000 as of its most recent filing with the SEC.

Several other institutional investors have also recently made changes to their positions in UNH. NewSquare Capital LLC bought a new stake in UnitedHealth Group during the fourth quarter valued at about $25,000. AlphaMark Advisors LLC bought a new position in UnitedHealth Group in the 4th quarter worth approximately $30,000. Promus Capital LLC bought a new stake in shares of UnitedHealth Group during the fourth quarter valued at approximately $32,000. Pillar Financial Advisors LLC bought a new position in shares of UnitedHealth Group during the fourth quarter worth $40,000. Finally, Legacy Investment Solutions LLC bought a new stake in UnitedHealth Group in the 3rd quarter valued at $57,000. Institutional investors own 87.86% of the company's stock.

UnitedHealth Group Trading Up 2.2 %

UNH traded up $11.32 on Monday, reaching $527.36. 2,887,666 shares of the company traded hands, compared to its average volume of 4,758,233. The company has a market cap of $482.38 billion, a P/E ratio of 34.00, a price-to-earnings-growth ratio of 1.37 and a beta of 0.62. The firm has a fifty day simple moving average of $508.81 and a two-hundred day simple moving average of $543.92. UnitedHealth Group Incorporated has a one year low of $436.38 and a one year high of $630.73. The company has a quick ratio of 0.91, a current ratio of 0.83 and a debt-to-equity ratio of 0.74.

Remove Ads

UnitedHealth Group (NYSE:UNH - Get Free Report) last released its quarterly earnings data on Thursday, January 16th. The healthcare conglomerate reported $6.81 EPS for the quarter, topping the consensus estimate of $6.74 by $0.07. UnitedHealth Group had a return on equity of 26.69% and a net margin of 3.60%. The company had revenue of $100.81 billion for the quarter, compared to the consensus estimate of $101.60 billion. During the same period last year, the business posted $5.83 EPS. UnitedHealth Group's quarterly revenue was up 6.8% on a year-over-year basis. As a group, equities research analysts expect that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current year.

UnitedHealth Group Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Tuesday, March 18th. Stockholders of record on Monday, March 10th were issued a $2.10 dividend. The ex-dividend date of this dividend was Monday, March 10th. This represents a $8.40 annualized dividend and a dividend yield of 1.59%. UnitedHealth Group's dividend payout ratio is currently 54.19%.

Insider Activity

In related news, Director Timothy Patrick Flynn bought 1,000 shares of the business's stock in a transaction on Friday, January 17th. The shares were bought at an average price of $511.57 per share, for a total transaction of $511,570.00. Following the completion of the purchase, the director now directly owns 4,500 shares of the company's stock, valued at approximately $2,302,065. This trade represents a 28.57 % increase in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Insiders own 0.33% of the company's stock.

Wall Street Analyst Weigh In

Several equities research analysts have recently issued reports on UNH shares. Cantor Fitzgerald reaffirmed an "overweight" rating and issued a $700.00 target price on shares of UnitedHealth Group in a report on Friday, January 17th. Deutsche Bank Aktiengesellschaft upped their price objective on UnitedHealth Group from $595.00 to $625.00 and gave the stock a "buy" rating in a report on Tuesday, December 3rd. Hsbc Global Res upgraded shares of UnitedHealth Group from a "hold" rating to a "strong-buy" rating in a research report on Friday, January 10th. Barclays dropped their price objective on shares of UnitedHealth Group from $655.00 to $642.00 and set an "overweight" rating for the company in a research note on Friday, January 17th. Finally, StockNews.com upgraded UnitedHealth Group from a "hold" rating to a "buy" rating in a research report on Thursday, January 23rd. Twenty investment analysts have rated the stock with a buy rating and two have given a strong buy rating to the company's stock. According to data from MarketBeat.com, the company presently has an average rating of "Buy" and an average target price of $629.32.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.